Related Experiment Video

Updated: Jun 9, 2026

Isolation of Intact, Whole Mouse Mammary Glands for Analysis of Extracellular Matrix Expression and Gland Morphology
12:49

Isolation of Intact, Whole Mouse Mammary Glands for Analysis of Extracellular Matrix Expression and Gland Morphology

Published on: October 30, 2017

Mammary-derived growth inhibitor (MDGI) interacts with integrin α-subunits and suppresses integrin activity and

J Nevo1, A Mai, S Tuomi

  • 1Medical Biotechnology, VTT Technical Research Centre of Finland, Turku, Finland.

Oncogene
|August 31, 2010
PubMed

Insights

Mammary-derived growth inhibitor (MDGI) binds to integrin alpha-subunits, inhibiting cancer cell migration and invasion. MDGI expression in breast cancer patients correlates with better survival, suggesting a role in favorable prognosis.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Cancer metastasis, driven by cell migration and invasion, is a major cause of mortality.
  • Integrin heterodimers mediate cell adhesion, crucial for migration and invasion processes.
  • While β1-integrin interactions are understood, regulatory partners for α-subunit cytoplasmic tails remain largely unknown.

Purpose of the Study:

  • To identify and characterize novel binding partners for integrin α-subunit cytoplasmic tails.
  • To investigate the functional role of mammary-derived growth inhibitor (MDGI) in integrin activity and breast cancer progression.

Main Methods:

  • Direct binding assays to confirm MDGI interaction with integrin α-subunits.
  • Analysis of integrin conformation and adhesion in breast cancer cell lines with varying MDGI expression.
  • Assessment of cell migration and invasion assays.
  • Retrospective analysis of MDGI expression in patient tumor tissue microarrays.

Main Results:

  • MDGI directly binds to integrin α-subunit cytoplasmic tails, inhibiting integrin activity.
  • MDGI expression suppresses the active conformation of integrins, reducing adhesion to collagen and fibronectin.
  • MDGI expression significantly inhibits breast cancer cell migration and invasion.
  • Patients with MDGI-positive tumors exhibited more favorable 10-year distant disease-free survival.

Conclusions:

  • MDGI is a novel interacting partner for integrin α-subunits, modulating integrin activity.
  • MDGI expression suppresses breast cancer cell invasion and is associated with a favorable prognosis.
  • MDGI represents a potential therapeutic target for reducing breast cancer metastasis.

More Related Videos

Intraductal Injection for Localized Drug Delivery to the Mouse Mammary Gland06:39

Intraductal Injection for Localized Drug Delivery to the Mouse Mammary Gland

Published on: October 4, 2013

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...